Analyst Price Target is $95.00
▲ +0.27% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Magellan Health in the last 3 months. The average price target is $95.00, with a high forecast of $95.00 and a low forecast of $95.00. The average price target represents a 0.27% upside from the last price of $94.74.
Current Consensus is
The current consensus among 2 investment analysts is to hold stock in Magellan Health. This rating has held steady since January 2020, when it changed from a Buy consensus rating.
Magellan Health, Inc. engages in the business of healthcare management. It operates through the following segments: Healthcare, Pharmacy Management and Corporate. The Healthcare segment includes the Behavioral & Specialty Health reporting unit, which provides carve-out management services for behavioral health, employee assistance plans, and other areas of specialty healthcare. The Pharmacy Management segment comprises of services that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit. The Corporate segment covers amounts not allocated to the Healthcare and Pharmacy Management segments. The company was founded in 1969 and is headquartered in Phoenix, AZ.